HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Ciaran McMullan Selected Research

AAL 881

3/2007Targeting BRAFV600E in thyroid carcinoma: therapeutic implications.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Ciaran McMullan Research Topics

Disease

7Neoplasms (Cancer)
09/2009 - 05/2003
5Thyroid Neoplasms (Thyroid Cancer)
12/2007 - 11/2003
3Heart Failure
01/2022 - 01/2021
3Retinoblastoma (Glioblastoma, Retinal)
09/2009 - 01/2005
2Hypertension (High Blood Pressure)
02/2017 - 01/2017
2Overweight
02/2017 - 01/2017
2Anaplastic Thyroid Carcinoma
10/2006 - 10/2003
2Multiple Myeloma
10/2006 - 05/2003
2Medullary Carcinoma
10/2006 - 05/2005
1Hypotension (Low Blood Pressure)
01/2022
1Anemia
11/2021
1Substance-Related Disorders (Drug Abuse)
01/2021
1Cytomegalovirus Infections (Inclusion Disease)
08/2017
1Infections
08/2017
1Proteinuria
08/2017
1Vitamin D Deficiency
02/2017
1Cutaneous T-Cell Lymphoma (Lymphoma, T Cell, Cutaneous)
09/2009
1Oncogene Addiction
12/2007
1Hematologic Neoplasms (Hematological Malignancy)
10/2006
1Hypoxia (Hypoxemia)
11/2003

Drug/Important Bio-Agent (IBA)

4Proteins (Proteins, Gene)FDA Link
12/2007 - 05/2003
3vericiguatIBA
01/2022 - 01/2021
3Histone Deacetylase InhibitorsIBA
09/2009 - 05/2003
3VorinostatFDA Link
09/2009 - 05/2003
2Bortezomib (Velcade)FDA Link
12/2007 - 10/2006
2Proteasome InhibitorsIBA
12/2007 - 10/2006
2Doxorubicin (Adriamycin)FDA LinkGeneric
12/2007 - 10/2006
2Complementary DNA (cDNA)IBA
12/2007 - 05/2005
2Insulin-Like Growth Factor I (IGF-1)IBA
10/2006 - 11/2003
2Death Domain ReceptorsIBA
05/2005 - 01/2005
2Caspase 8 (Caspase-8)IBA
05/2005 - 01/2005
1sacubitril and valsartan sodium hydrate drug combinationIBA
01/2022
1Hemoglobins (Hemoglobin)IBA
11/2021
1NitratesIBA
01/2021
1TOR Serine-Threonine KinasesIBA
08/2017
1Calcineurin InhibitorsIBA
08/2017
1Vitamin DFDA LinkGeneric
02/2017
1hydroxide ionIBA
02/2017
125-hydroxyvitamin DIBA
02/2017
1Ergocalciferols (Ergocalciferol)FDA LinkGeneric
02/2017
1Uric Acid (Urate)IBA
01/2017
1Probenecid (Benemid)FDA LinkGeneric
01/2017
1Allopurinol (Remid)FDA LinkGeneric
01/2017
1Histone Deacetylases (Histone Deacetylase)IBA
09/2009
1MAP Kinase Kinase Kinases (MAP Kinase Kinase Kinase)IBA
03/2007
1MitogensIBA
03/2007
1RNA (Ribonucleic Acid)IBA
03/2007
1AAL 881IBA
03/2007
1Proto-Oncogene Proteins B-rafIBA
03/2007
1Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA
03/2007
1Antineoplastic Agents (Antineoplastics)IBA
10/2006
1NF-kappa B (NF-kB)IBA
10/2006
1Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA
05/2005
1AcidsIBA
05/2005
1CaspasesIBA
05/2005
1Monoclonal AntibodiesIBA
01/2005
1Transcription Factor AP-1 (Transcription Factor AP 1)IBA
11/2003
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
11/2003
1Transcription Factors (Transcription Factor)IBA
11/2003
1geldanamycinIBA
11/2003
1Imatinib Mesylate (Gleevec)FDA Link
10/2003
1Hydroxamic Acids (Hydroxamic Acid)IBA
05/2003

Therapy/Procedure

3Drug Therapy (Chemotherapy)
12/2007 - 05/2005
1Therapeutics
12/2007